XtalPi climbs to 4-week high on Laboratoires Pierre Fabre tie-up

** Shares of XtalPi Holdings 2228.HK climb 5.3% to HK$6.45, their highest level since October 14

** Stock on course for the biggest one-day pct gain since October 9; 7th biggest pct gainer in the Hang Seng Biotech Index .HSBIO, which rises 2.7%

** Drug and material science research and development solutions provider says its units have entered into AI-driven drug discovery collaboration with Pierre Fabre Médicament SAS of southwest France-based Laboratoires Pierre Fabre Group

** The firms will collaborate on the discovery of novel clinical candidates across a number of research programmes in oncology, and potentially dermatology and rare diseases

** YTD, XtalPi shares down 33.1%, benchmark Hang Seng Index .HSI down 4%